Trial Profile
Treatments for Fathers With ADHD and Their At-Risk Children (Fathers Too)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Sep 2018
Price :
$35
*
At a glance
- Drugs Lisdexamfetamine (Primary) ; Methylphenidate
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- Acronyms Fathers Too
- 10 Sep 2018 Status changed from recruiting to completed.
- 18 Feb 2016 New trial record